Eduardo S Ghisolfi

Summary

Affiliation: Porto Alegre
Country: Brazil

Publications

  1. ncbi Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence
    Eduardo S Ghisolfi
    Departamento de Bioquímica do Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul UFRGS, Rua Ramiro Barcelos, 2600 Anexo, Porto Alegre, RS, 90050 003 Brazil
    Int J Psychophysiol 51:209-14. 2004
  2. ncbi Impaired P50 sensory gating in Machado-Joseph disease
    Eduardo S Ghisolfi
    Departamento de Bioquímica da Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
    Clin Neurophysiol 115:2231-5. 2004
  3. ncbi Caffeine modulates P50 auditory sensory gating in healthy subjects
    Eduardo S Ghisolfi
    Departamento de Ciencias Fisiologicas, Faculdade de Biociencias, PUCRS, Porto Alegre, Brazil
    Eur Neuropsychopharmacol 16:204-10. 2006
  4. ncbi P50 sensory gating in panic disorder
    Eduardo S Ghisolfi
    Departamento de Ciencias Fisiologicas, Faculdade de Biociências da, Pontificia Universidade Catolica do Rio Grande do Sul, Av Ipiranga, 6681 Prédio 12 A, 90619 900 Porto Alegre, RS, Brazil
    J Psychiatr Res 40:535-40. 2006
  5. ncbi Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia
    Jefferson Becker
    Neurology Service, Hospital Sao Lucas, Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil
    Clin Neurophysiol 115:396-401. 2004
  6. ncbi The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects
    Eduardo S Ghisolfi
    Departamento de Bioqui;mica, , Universidade Federal do Rio Grande do Sul, UFRGS, RS, Porto Alegre, Brazil
    Neuropsychopharmacology 27:629-37. 2002
  7. ncbi A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia
    Miriam G Brunstein
    Department of Biochemistry, Health Basic Science Institute, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
    J Clin Psychiatry 66:213-9. 2005
  8. ncbi Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications
    Diogo R Lara
    Departamento de Ciencias Fisiologicas, Faculdade de Biociencias, PUCRS, Porto Alegre, Brazil
    Prog Neuropsychopharmacol Biol Psychiatry 30:617-29. 2006
  9. ncbi Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides
    Rosane Maria Salvi
    , , , Porto Alegre, Brazil
    Toxicol Sci 72:267-71. 2003

Collaborators

Detail Information

Publications9

  1. ncbi Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence
    Eduardo S Ghisolfi
    Departamento de Bioquímica do Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul UFRGS, Rua Ramiro Barcelos, 2600 Anexo, Porto Alegre, RS, 90050 003 Brazil
    Int J Psychophysiol 51:209-14. 2004
    ..The P50 paradigm may also become an objective parameter to assess the effects of new treatments for PTSD...
  2. ncbi Impaired P50 sensory gating in Machado-Joseph disease
    Eduardo S Ghisolfi
    Departamento de Bioquímica da Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
    Clin Neurophysiol 115:2231-5. 2004
    ..1, is a disorder with wide range of neurological findings and brain regions involved. Studies evaluating neurophysiological parameters related to sensory gating in MJD are lacking...
  3. ncbi Caffeine modulates P50 auditory sensory gating in healthy subjects
    Eduardo S Ghisolfi
    Departamento de Ciencias Fisiologicas, Faculdade de Biociencias, PUCRS, Porto Alegre, Brazil
    Eur Neuropsychopharmacol 16:204-10. 2006
    ..These results reinforce the participation of adenosine in the modulation of P50 sensory gating and suggest that caffeine ingestion should be controlled for in the P50 sensory gating paradigm...
  4. ncbi P50 sensory gating in panic disorder
    Eduardo S Ghisolfi
    Departamento de Ciencias Fisiologicas, Faculdade de Biociências da, Pontificia Universidade Catolica do Rio Grande do Sul, Av Ipiranga, 6681 Prédio 12 A, 90619 900 Porto Alegre, RS, Brazil
    J Psychiatr Res 40:535-40. 2006
    ..Further studies are still necessary to better understand the pathophysiology of this neurophysiological dysfunction and its nature as a trait or a state marker...
  5. ncbi Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia
    Jefferson Becker
    Neurology Service, Hospital Sao Lucas, Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil
    Clin Neurophysiol 115:396-401. 2004
    ....
  6. ncbi The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects
    Eduardo S Ghisolfi
    Departamento de Bioqui;mica, , Universidade Federal do Rio Grande do Sul, UFRGS, RS, Porto Alegre, Brazil
    Neuropsychopharmacology 27:629-37. 2002
    ....
  7. ncbi A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia
    Miriam G Brunstein
    Department of Biochemistry, Health Basic Science Institute, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
    J Clin Psychiatry 66:213-9. 2005
    ..P50 auditory sensory gating failed to improve with allopurinol treatment. CONCLUSIONS: Allopurinol was an effective and well-tolerated adjuvant treatment for poorly responsive schizophrenia, especially for refractory positive symptoms...
  8. ncbi Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications
    Diogo R Lara
    Departamento de Ciencias Fisiologicas, Faculdade de Biociencias, PUCRS, Porto Alegre, Brazil
    Prog Neuropsychopharmacol Biol Psychiatry 30:617-29. 2006
    ..Since much of the evidence for the adenosine hypothesis is preliminary and theoretical, further investigation in the field is warranted...
  9. ncbi Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides
    Rosane Maria Salvi
    , , , Porto Alegre, Brazil
    Toxicol Sci 72:267-71. 2003
    ....